SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced the appointment of Dr. Jixun Lin as independent director. Dr. Lin replaces Andrew Wolff on the company's board of directors.
"We are delighted to welcome Dr. Lin to our board," said Xu Hang, Mindray's chairman and co-chief executive officer. "Dr. Lin is a leader in the global medical device industry and we are confident that his experience and expertise will be of great benefit to Mindray as we continue to expand into new markets around the world."
"We are very thankful for Mr. Wolff's service on our board. We appreciate his valuable contributions since his appointment and for his willingness to serve on our board after our IPO," added Mr. Xu. Andrew Wolff, managing director of Goldman Sachs, served as Mindray's independent director since February 2006.
Dr. Jixun Lin is founder and chief executive officer of ACON Laboratories Inc., a worldwide leading manufacturer of high-quality rapid diagnostic test products. Dr. Lin founded ACON Laboratories Inc. in 1995 and serves on the company's board of directors. He also serves on the board of directors for ACEA BioSciences Inc., a company providing innovative cell-based assay systems for basic life science research and drug discovery. Mr. Lin received his Ph.D. in microbiology and immunology from the Medical University of South Carolina and a Bachelor of Medicine from Zhejiang Medical University.
Mindray's board now consists of three Mindray officers, Xu Hang
(chairman and co-chief executive officer), Li Xiting (p
|SOURCE Mindray Medical International Limited|
Copyright©2007 PR Newswire.
All rights reserved